Skip to content
    aMoon logo

    aMoon

    Ra'anana, IsraelFounded 2016
    www.amoon.fundLinkedIn
    Biotech & Life SciencesHealthcare

    aMoon is a global HealthTech and Life Sciences venture capital fund based in Israel, partnering with entrepreneurs who harness groundbreaking science and technology to transform healthcare. The firm operates through aMoon Velocity (early-stage) and aMoon Growth (growth-stage) funds, investing in biopharma, medtech, and digital health companies across the US, Europe, and Israel.

    Average disclosed round size is $49.3M (across 44 rounds with reported amounts).

    Find people at aMoon on Goldilocks AI

    Portfolio

    45

    Fund Size

    $750M

    Top Stage

    Series C

    Last 12 Mo

    2

    Team

    Yair Schindel, MD, MBA

    Yair Schindel, MD, MBA

    Co-Founder & Managing Partner

    Tomer Berkovitz, PhD

    Tomer Berkovitz, PhD

    Managing Partner

    Moshic Mor, MBA

    Moshic Mor, MBA

    General Partner

    Todd Sone, MBA

    Todd Sone, MBA

    General Partner

    Yaron Daniely, PhD, MBA

    Yaron Daniely, PhD, MBA

    General Partner & Head of aMoon Alpha

    Reut Shema, PhD

    Reut Shema, PhD

    Partner

    Roy Wiesner, Adv., MPA

    Roy Wiesner, Adv., MPA

    Partner

    Adam Kotzen

    Adam Kotzen

    Principal

    Gaby Hirsch

    Gaby Hirsch

    VP Investor Relations

    Yodfat Melzer, CPA, MBA

    Yodfat Melzer, CPA, MBA

    VP Finance

    Daniel Sass, MD, MBA

    Daniel Sass, MD, MBA

    Associate

    Hagai Marmor-Kollet, PhD

    Hagai Marmor-Kollet, PhD

    Associate

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    54 investments
    CompanyRoundAmountDate
    LLin HealthSeries A$11MDec 2025
    Adcytherix logoAdcytherixSeries A—Oct 2025
    Iantrek, Inc logoIantrek, IncSeries C$42MAug 2025
    MAGENTIQ EYE logoMAGENTIQ EYESeries A—Jul 2025
    LLutris PharmaUnknown$30MJan 2025
    IIantrekSeries C—Jan 2025
    Lyfegen logoLyfegenSeries A$8MDec 2024
    MMetaSight DiagnosticsSeries A$8MNov 2024
    Air Doctor logoAir DoctorSeries B$20MOct 2024
    MMetaSightSeries A$8MJan 2024
    IBEX logoIBEXSeries C$55MSep 2023
    IIbex Medical AnalyticsSeries C$55MSep 2023
    Better Life Partners logoBetter Life PartnersSeries B$26.5MAug 2023
    NNectin TherapeuticsSeries A—Nov 2022
    Theranica Bio-Electronics logoTheranica Bio-ElectronicsSeries C$45MAug 2022
    Ultima Genomics logoUltima GenomicsGrowth—May 2022
    Omada Health logoOmada HealthSeries E$192MFeb 2022
    Lyfegen logoLyfegenUnknown$8MJan 2022
    MOBILion Systems, Inc. logoMOBILion Systems, Inc.Series C$60MJul 2021
    Kahr logoKahrUnknown$46.5MJun 2021
    AltruBio logoAltruBioSeries A$63MApr 2021
    IBEX logoIBEXSeries B$38MMar 2021
    SScipher MedicineSeries C$82MJan 2021
    Amylyx Pharmaceuticals logoAmylyx PharmaceuticalsSeries C—Jan 2021
    SOPHiA GENETICS logoSOPHiA GENETICSSeries F$110MOct 2020
    Page 1 of 3

    Top Co-Investors

    Lightspeed Venture Partners5 shared
    Khosla Ventures5 shared
    Johnson & Johnson Innovation4 shared
    Fidelity Investments4 shared
    Peregrine Ventures4 shared
    Pontifax3 shared
    Octopus Ventures3 shared
    83North3 shared
    Planven Entrepreneur Ventures3 shared
    Dell Technologies Capital3 shared
    Civilization Ventures3 shared
    Hitachi Ventures3 shared
    Alumni Ventures3 shared
    Domain Associates3 shared
    LionBird2 shared
    OurCrowd2 shared
    Dolby Family Ventures2 shared
    Intermountain Health2 shared
    D1 Capital Partners2 shared
    Agilent Technologies2 shared

    Last updated: 8 September 2026